PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma

M. Imran Aslam, Jinu Abraham, Atiya Mansoor, Brian Druker, Jeffrey Tyner, Charles Keller

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Alveolar rhabdomyosarcoma (aRMS) is an aggressive myogenic childhood malignancy, not infrequently presenting as incurable metastatic disease. To identify therapeutic targets, we performed an unbiased tyrosine kinome RNA interference screen in primary cell cultures from a genetically engineered, conditional mouse model of aRMS. We identified ephrin receptor B4 (EphB4) as a target that is widely expressed in human aRMS and that portends a poor clinical outcome in an expression level-dependent manner. We also uncovered cross-talk of this ephrin receptor with another receptor tyrosine kinase, PDGFRβ, which facilitates PDGF ligand-dependent, ephrin ligand-independent activation of EphB4 converging on the Akt and Erk1/2 pathways. Conversely, EphB4 activation by its cognate ligand, EphrinB2, did not stimulate PDGFRβ; instead, apoptosis was paradoxically induced. Finally, we showed that smallmolecule inhibition of both PDGFRβ and EphB4 by dasatinib resulted in a significant decrease in tumor cell viability in vitro, as well as decreased tumor growth rate and significantly prolonged survival in vivo. To our knowledge, these results are the first to identify EphB4 and its cross-talk with PDGFRβ as unexpected vital determinants of tumor cell survival in aRMS, with EphB4 at the crux of a bivalent signaling node that is either mitogenic or proapoptotic.

Original languageEnglish (US)
Pages (from-to)6383-6388
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume111
Issue number17
DOIs
StatePublished - Apr 29 2014

Fingerprint

Alveolar Rhabdomyosarcoma
Eph Family Receptors
Ligands
Neoplasms
Cell Survival
Ephrins
Primary Cell Culture
Receptor Protein-Tyrosine Kinases
RNA Interference
Tyrosine
Apoptosis
Survival

Keywords

  • Muscle
  • Pediatric
  • Sarcoma

ASJC Scopus subject areas

  • General

Cite this

PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma. / Aslam, M. Imran; Abraham, Jinu; Mansoor, Atiya; Druker, Brian; Tyner, Jeffrey; Keller, Charles.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, No. 17, 29.04.2014, p. 6383-6388.

Research output: Contribution to journalArticle

Aslam, M. Imran ; Abraham, Jinu ; Mansoor, Atiya ; Druker, Brian ; Tyner, Jeffrey ; Keller, Charles. / PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma. In: Proceedings of the National Academy of Sciences of the United States of America. 2014 ; Vol. 111, No. 17. pp. 6383-6388.
@article{8bd1d11b9b1e4f3391bb97d8446ccc87,
title = "PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma",
abstract = "Alveolar rhabdomyosarcoma (aRMS) is an aggressive myogenic childhood malignancy, not infrequently presenting as incurable metastatic disease. To identify therapeutic targets, we performed an unbiased tyrosine kinome RNA interference screen in primary cell cultures from a genetically engineered, conditional mouse model of aRMS. We identified ephrin receptor B4 (EphB4) as a target that is widely expressed in human aRMS and that portends a poor clinical outcome in an expression level-dependent manner. We also uncovered cross-talk of this ephrin receptor with another receptor tyrosine kinase, PDGFRβ, which facilitates PDGF ligand-dependent, ephrin ligand-independent activation of EphB4 converging on the Akt and Erk1/2 pathways. Conversely, EphB4 activation by its cognate ligand, EphrinB2, did not stimulate PDGFRβ; instead, apoptosis was paradoxically induced. Finally, we showed that smallmolecule inhibition of both PDGFRβ and EphB4 by dasatinib resulted in a significant decrease in tumor cell viability in vitro, as well as decreased tumor growth rate and significantly prolonged survival in vivo. To our knowledge, these results are the first to identify EphB4 and its cross-talk with PDGFRβ as unexpected vital determinants of tumor cell survival in aRMS, with EphB4 at the crux of a bivalent signaling node that is either mitogenic or proapoptotic.",
keywords = "Muscle, Pediatric, Sarcoma",
author = "Aslam, {M. Imran} and Jinu Abraham and Atiya Mansoor and Brian Druker and Jeffrey Tyner and Charles Keller",
year = "2014",
month = "4",
day = "29",
doi = "10.1073/pnas.1403608111",
language = "English (US)",
volume = "111",
pages = "6383--6388",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "17",

}

TY - JOUR

T1 - PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma

AU - Aslam, M. Imran

AU - Abraham, Jinu

AU - Mansoor, Atiya

AU - Druker, Brian

AU - Tyner, Jeffrey

AU - Keller, Charles

PY - 2014/4/29

Y1 - 2014/4/29

N2 - Alveolar rhabdomyosarcoma (aRMS) is an aggressive myogenic childhood malignancy, not infrequently presenting as incurable metastatic disease. To identify therapeutic targets, we performed an unbiased tyrosine kinome RNA interference screen in primary cell cultures from a genetically engineered, conditional mouse model of aRMS. We identified ephrin receptor B4 (EphB4) as a target that is widely expressed in human aRMS and that portends a poor clinical outcome in an expression level-dependent manner. We also uncovered cross-talk of this ephrin receptor with another receptor tyrosine kinase, PDGFRβ, which facilitates PDGF ligand-dependent, ephrin ligand-independent activation of EphB4 converging on the Akt and Erk1/2 pathways. Conversely, EphB4 activation by its cognate ligand, EphrinB2, did not stimulate PDGFRβ; instead, apoptosis was paradoxically induced. Finally, we showed that smallmolecule inhibition of both PDGFRβ and EphB4 by dasatinib resulted in a significant decrease in tumor cell viability in vitro, as well as decreased tumor growth rate and significantly prolonged survival in vivo. To our knowledge, these results are the first to identify EphB4 and its cross-talk with PDGFRβ as unexpected vital determinants of tumor cell survival in aRMS, with EphB4 at the crux of a bivalent signaling node that is either mitogenic or proapoptotic.

AB - Alveolar rhabdomyosarcoma (aRMS) is an aggressive myogenic childhood malignancy, not infrequently presenting as incurable metastatic disease. To identify therapeutic targets, we performed an unbiased tyrosine kinome RNA interference screen in primary cell cultures from a genetically engineered, conditional mouse model of aRMS. We identified ephrin receptor B4 (EphB4) as a target that is widely expressed in human aRMS and that portends a poor clinical outcome in an expression level-dependent manner. We also uncovered cross-talk of this ephrin receptor with another receptor tyrosine kinase, PDGFRβ, which facilitates PDGF ligand-dependent, ephrin ligand-independent activation of EphB4 converging on the Akt and Erk1/2 pathways. Conversely, EphB4 activation by its cognate ligand, EphrinB2, did not stimulate PDGFRβ; instead, apoptosis was paradoxically induced. Finally, we showed that smallmolecule inhibition of both PDGFRβ and EphB4 by dasatinib resulted in a significant decrease in tumor cell viability in vitro, as well as decreased tumor growth rate and significantly prolonged survival in vivo. To our knowledge, these results are the first to identify EphB4 and its cross-talk with PDGFRβ as unexpected vital determinants of tumor cell survival in aRMS, with EphB4 at the crux of a bivalent signaling node that is either mitogenic or proapoptotic.

KW - Muscle

KW - Pediatric

KW - Sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84899650764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899650764&partnerID=8YFLogxK

U2 - 10.1073/pnas.1403608111

DO - 10.1073/pnas.1403608111

M3 - Article

C2 - 24733895

AN - SCOPUS:84899650764

VL - 111

SP - 6383

EP - 6388

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 17

ER -